Nike and Hyperice's $900 ‘Recovery' Boot Lives Up to the Hype

If you're an athlete, then you remember all too well that the time between 2015 and 2020 was when recovery tools really took over. While hard to believe, there was, in fact, a time when a hard workout or a weekend long run didn't end with a session in Normatec Legs or a bout with a massage gun. But in 2025, athletes of all ranges, from pro to amateur level, and in nearly every sport, have made recovery a key component of their training. In line with this notion are the novel tech and tools that athletes now have access to. Think Normatec boots and Hyperice massage guns, yes, but also at-home portable cupping, red light therapy, TENS (transcutaneous electrical nerve stimulation) devices, and infrared sauna blankets, to name just a few. The latest in this lineup is the Hyperboot, an extremely high-tech pair of recovery boots that are priced at $899.
The Hyperboot is somewhat of a mashup between an ultra-comfy and supportive recovery shoe—which many sportswear companies have released in the past several years—and a compression boot, but one specifically designed to provide recovery support to the foot and ankle. They're a collaboration between Nike, which is responsible for the bulk of the shoe design, including the mid and outer soles, and Hyperice, a company that makes high-end recovery tools for athletes.
Hyperice x Nike Hyperboot
Nike and Hyperice's Hyperboots will make your feet feel fresh and relaxed after working out, but $900 is steep for the specialized recovery shoes.
Pros Remarkably relaxing
Remarkably relaxing Easy setup
Easy setup TSA-approved for carry-on
Cons Bulky, weird-looking
Bulky, weird-looking Very expensive
What Do They Do and Why Do They Look So Weird?
The Hyperboot is not discreet. They are big and bulky and look like they are meant to accompany an astronaut on a moonwalk. Though by now, most runners, casual and professional, are used to colossal-sized running shoes, these are larger still—and by a lot. The reason for the chunkiness, and the secret sauce of these recovery shoes, is that they have the same built-in air compression technology that you'll find in the Normatec boots (Hyperice bought Normatec in 2020).
Better known as intermittent pneumatic compression (IPC) devices, they use a system of air pumps and chambers to inflate and deflate in a regularly repeating pattern. The idea behind this is that by expanding and collapsing in a systematic way, blood flow and the movement of lymphatic fluid increases, allowing for better circulation and removal of waste, and, theoretically, faster recovery—all while you are seated, resting and relaxing.
In addition to this squeezing technology, the Hyperboot added one more feature: heat. While you are getting your feet and ankles squeezed, the device heats up. Because heat is known to relax muscles, adding it in with the compression technology should enable even more blood flow and fluid movement; also, heat just feels really nice.
What Do the Boots Feel Like?
Unfortunately, I don't hate them. I say unfortunately because truly, who actually wants to fall in love with a $900 recovery shoe?
Unlike the Normatec boots or similar compression sleeves from other brands, the Hyperboot is meant to be both a recovery and warm-up device, meaning that to get the most benefits from them, the shoes should be worn both before and after a workout. Runners and other athletes often fall into three camps: they are warm-up stans, recovery devotees, or both. I fall into the oft-forgotten fourth category: I despise—and purposefully forget about—both. But for the sake of this review, I pretended I belonged firmly in the third category.
During my two-week stint wearing the Hyperboot before and after every single run—I promise!—which ranged from easy three-to-five-mile runs, a couple faster interval workouts, and an 8-mile longer run on the weekend, I found myself looking forward to my workouts solely because that meant I got to spend some time in the boots. Having spent a decent amount of my free time in Normatec Legs during numerous marathon builds circa 2018 through 2022, I know the 'fresh legs' feeling these devices can create. It's an undeniably gloriously light, airy experience. The new Hyperboots did not disappoint on this front. And the addition of heat created this feeling of stepping into one of those foot baths with a massager, but without the added messy water setup and cleanup.
The setup of the boots themselves was straightforward. The boots are charged via two USB-C cords that are plugged into a wall charger. The charge will last for about 1.5 hours (that is plenty of time in the boots; see below.) There are four buttons: an on/off button, a compression button, a heat button, and a start/stop button. Both the compression and heat buttons have three ranges of intensity.
Once you've strapped in and turned the device on, the Hyperboots will compress to each foot. Pressing the start/stop button will begin the sequential compressions and heat. At first, I turned both settings—compression and heat strength—up to max. While the intense compressions were not bothersome (rather the opposite), the heat quickly became unbearable. The heat ranges in intensity from 111-degree Fahrenheit on the lowest level to 125-degree Fahrenheit on the highest level. Be warned: the highest level was so hot that I had to remove the shoes mid-session (though not so hot that I had to run them under cold water or I got a burn, don't worry). I've since learned that either I'm a wimp when it comes to heat or the boots are simply too hot. Either way, I was only able to tolerate the shoes on the lowest possible heat setting. Even with that setting though, the feeling of a hot water bath comes through just fine.
I was surprised how much the shoes made my feet and ankles feel fresh, relaxed, and equally refreshed to begin a workout, as well as restored if I had just recovered from one. The main concept behind the boots, according to Hyperice and Nike, is that your ankles and feet are important but both forgotten and tricky areas to treat. Technically, the Normatec Legs do cover your feet and ankles, so if you already own a pair of them (and they are the exact same price as the Hyperboot right now), you might be wondering what more the Hyperboot can provide.
Having tried both, I will say that the Hyperboot provides a more targeted compression of the ankle compared to the Normatec Legs, and once you've finished, you can really feel the difference. The Hyperboot made my ankles feel light, airy, and ready for my next workout. Just as significantly, the addition of heat was not insignificant. It made a notable difference—subjectively!—to how I felt after wearing them.
Technically speaking, the shoes are designed so that you can stand, walk, sit, or travel all while getting the compression and heat benefits. On that note, the shoes are TSA-approved for carry-on, according to Hyperice. But also on that note, if I am being blunt, I had a lot of trouble forcing myself to leave my apartment in these shoes. Inside my apartment, I could wear them for hours all while cleaning, cooking, and doing other housework. The midsoles are extremely comfortable and the boots, in general, have a propeller-like feel similar to the feeling of wearing carbon plate racing shoes. However, I did feel like I got the most benefit from them just by sitting down, relaxing, and letting the compression and heat work. And, because I care deeply about my readers, I forced myself to wear them outside twice: once to get coffee and walk around my neighborhood and another time to a grocery store. Many people looked at my feet. Nobody asked questions.
Do They Actually Help You Recover Faster? What Does the Science Say?
It's undeniable that these shoes make your feet happy. But how does that translate into true recovery? And what evidence do we have to back that up? That's where things get trickier.
The compression device technology was originally developed for bed-bound hospitalized patients to prevent blood clots. The periodic compressions mimic what would happen if someone were to, say, walk the length of a hospital wing, which is probably the same distance as one city block or less. Doctors knew that prolonged immobility increased the risk for blood to clot, so by mimicking movement, these boots would reduce the risk of these dangerous clots in a person who couldn't move. Later on, the founder of Normatec, a doctor named Laura Jacobs, further refined these devices to specifically help people dealing with postoperative lymphedema in breast cancer. Her device was then introduced to the athletic community as the Normatec Legs. If it can help blood flow and lymphatic drainage in immobile, hospitalized people, then it might help athletes, too.
But there's a catch to this. The difference between an athlete—from elite to amateur—and an immobile patient in the hospital recovering from surgery is that an athlete can walk a city block. And unfortunately, there's still little evidence to suggest that these compression devices do anything more for recovery than a walk can provide. The Hyperboot is new, so there aren't independent studies on its effectiveness. However, since the Normatec Legs came out, there have been a number of studies looking into whether these devices help in recovery.
A 2020 study published in the International Journal of Exercise Science followed 10 distance runners (five female and five male runners) and monitored how they felt after runs that ended in a session with compression boots (Normatec Legs or ones similar) and runs that didn't include a post-run session. The study concluded that 'there appear to be no substantial benefits of IPC in promoting recovery.' A 2024 meta-analysis, which pulls together a bulk of studies all on the same subjects and looks for overall trends, published in the journal Biology of Sport, looked at 17 studies, which included a total of 319 participants, and concluded that the boots provided 'a trivial to moderate effect' on pain and muscle soreness markers and 'a highly variable effect' on markers that look at muscle damage. The authors found that this technology 'might be a method with potential effects for recovery in sports, mainly reducing perceived soreness.'
The problem is that, as Christie Aschwanden, author of Good to Go, about the science of athletic recovery, told Runner's World, it's really hard to measure what recovery is or means as 'there's no single physiological measure—not heart rate, body temperature, or hydration status—that will tell you whether or not you're recovered.' In fact, 'How do you feel?' is a common way to monitor recovery.
In that vein, the Hyperboot did make me feel good. I felt better after wearing the boots than I did before putting them on. This was true every time I wore them. And I looked forward to wearing them, so much that they made me look forward to harder workouts that I otherwise was somewhat dreading. However, at $900, if I could get the same benefit that the Hyperboot provides by walking to and from the park where I run instead of starting my run as soon as I leave my apartment, I'd probably opt for that. Though it wouldn't be as relaxing or fun.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Forbes

17 minutes ago

• Forbes

Why Smoking Is Making A Comeback — And What It Means For Your Health

Gen Z is picking up where past generations left off—with a cigarette in hand. A cigarette lit on screen once symbolized noir, danger and cool detachment — think Bogart or David Lynch. Then came the lawsuits, anti-smoking campaigns, bans and the rise of vaping. For a while, it seemed America had finally kicked the habit. But now, a smoking comeback is underway. Zendaya lights up in 'Euphoria'; Jacob Elordi does the same in 'Saltburn.' Celebrities like Dua Lipa, Charli XCX, Timothée Chalamet and Anya Taylor-Joy have been spotted puffing away, becoming modern-day "cigfluencers." In 2020, cigarette sales rose for the first time in decades — though still far below the 1981 peak of 636.5 billion. Even among teens, nicotine use is shifting from vapes back to traditional cigarettes. A recent report by Truth Initiative found that tobacco depictions in top films have increased for the first time since tracking began in 2002. So what can we do? From Trend to Relapse We've been here before. In the early 20th century, cigarette smoking was glamorized in Hollywood, normalized by doctors and deeply embedded in American life. By the 1960s, nearly half of U.S. adults smoked. Then came the fallout: emphysema, heart disease, stroke, lung cancer. The medical evidence caught up with the image. Public health campaigns, warning labels, advertising bans and billions in legal settlements helped turn the tide. Not to mention, the astronomical price for a pack of cigarettes and the fact that there's no longer any places to smoke in public. The 2020 Surgeon General's report marked a historic milestone: adult cigarette smoking in the U.S. had fallen to just 14% — the lowest rate ever recorded. It was one of the greatest public health wins of the modern era. But smoking never truly disappeared. It shape-shifted. First into cigars and hookahs, then into sleek USB-like vape devices. Vaping was marketed as a safer alternative — a harm-reduction strategy. But the reality is more complicated. Juul didn't kill the cigarette. It trained a new generation to inhale nicotine. Now, we're seeing a strange reversal: from vape to smoke. From digital detox to vintage, Instagrammable vice. And once again, public health is playing catch-up to pop culture. A Healthcare Advisor's Take: Why This Matters Now In my work advising families, executives and individuals navigating complex health decisions, I've learned one truth: the greatest threats aren't the ones making headlines. They're the silent resurgences — the risks we assumed were relegated to history. Like measles. For over 20 years, we nearly eradicated it. Vaccines turned a once-common childhood illness into a relic. But now, declining vaccination rates and global travel have breathed life back into this preventable disease. Outbreaks are flaring in communities we thought were protected. Same goes for whooping cough. The resurgence of smoking may look like an edgy accessory for Gen Z. But it has real consequences, especially for anyone with a family history of heart or lung disease. What makes this moment so dangerous is the normalization. When something taboo gets rebranded as a choice — even a form of rebellion — it catches many with their guard down. People start saying things like: 'I'm just a social smoker.' 'At least it's not vaping.' 'I don't inhale.' These are the same rationalizations we heard in the 1980s. We already know where they lead. Why the Anti-Smoking Playbook of the '90s Worked — and Why It's Not Enough Now Remember those visceral commercials from the Truth Initiative? Or the public testimonies from people with tracheostomies begging kids not to smoke? Those campaigns worked because they made the consequences impossible to ignore. They also had something else: funding, legislation and social momentum. Today, the cultural winds are different. Social media algorithms reward aesthetics, not public health. TikTok doesn't run public service announcements. And with vaping muddying the waters, many young people don't even understand what they're inhaling — or how much. ​​Legislating Against the Cigarette Comeback Even as smoking regains cultural cachet, some states are pushing back with unprecedented measures. Nevada could soon make history by becoming the first U.S. state to outlaw cigarette sales to entire generations. A proposed law (AB 279) would permanently ban sales to anyone born after 2004 — a rising age restriction designed to phase out cigarettes entirely. What's Actually in a Cigarette For all the romanticization, cigarettes remain one of the deadliest consumer products ever marketed. A single cigarette contains more than 7,000 chemicals — 69 of which are known to cause cancer. Smoking contributes to 1 in 5 deaths in the U.S. each year. And it doesn't just affect the lungs. The one question I'll guarantee your doctor will ask for your next annual checkup is this: do you smoke? Smoking increases your risk of: It also accelerates aging, damages skin elasticity and reduces stamina — none of which pairs particularly well with the image of glamour it's trying to recapture. So Why Is Gen Z Smoking? There's no one answer. But here are a few forces at play: So What Can You Do? If you're a parent, provider or simply trying to keep yourself on a healthier path, here's what I advise: In healthcare, it's easy to focus only on diagnoses and prescriptions. But as advisors, we have to stay attuned to the cultural cues — the smoke signals — that precede behavior. When the smoking comeback starts trending again, it's not just an aesthetic choice. It's a public health flare. And if we don't speak up early, we may find ourselves fighting an old war with new casualties. So the next time someone says, 'It's just one,' don't ignore it. Intervene with empathy, context, and truth. Because this time, we know better.

Health Line

21 minutes ago

• Health Line

GLP-1 Weight Loss Results Not as Effective in Everyday Life, Study Finds

Researchers report that people taking GLP-1 drugs in daily life don't lose as much weight as those in clinical trials who take the same medications. The researchers add that people using weight loss drugs don't regain weight as quickly as those in clinical trials. One possible reason for the weight loss differential is that people in the 'real world' tend to stop taking these medications sooner than people in clinical trials. People who use commonly prescribed weight loss medications don't lose as much weight as participants in clinical trials, but they also don't regain weight as quickly. That's the conclusion of a new study published on June 10 in the journal Obesity. The study authors reported that the weight loss differential was mainly due to the fact that people tend to stop using GLP-1 drugs sooner than clinical trial participants. They also tend to use lower doses of these medications. The researchers also reported that A1C blood level reductions were similar for both groups of people. The researchers noted that they will initiate further research into what other measures, such as lifestyle changes or bariatric surgery, people may have adopted after discontinuing weight loss medications such as Wegovy and Zepbound. The researchers also want to look into why people stopped using weight loss drugs before their program regimen ended. 'Our findings indicate that treatment discontinuation and use of lower maintenance dosages might reduce the likelihood of achieving clinically meaningful weight reduction in patients who initiate obesity pharmacotherapy with semaglutide or tirzepatide,' the study authors wrote. 'Our findings could inform the decisions of healthcare providers and their patients on the role of treatment discontinuation and maintenance dosage in achieving clinically meaningful weight loss,' they added. 'Real world' use of weight loss medications For their study, researchers looked at the health records of 7,881 adults with obesity or weight management issues who did not have type 2 diabetes. Those people were seen between 2021 and 2023 at the Cleveland Clinic's facilities in Ohio and Florida. Their average age was about 51 years. Nearly 80% of the subjects were white. Of those participants, 6,109 were prescribed a weight loss medication such as Wegovy with the active ingredient semaglutide. The other 1,772 were prescribed a weight loss drug, such as Zepbound, with the active ingredient tirzepatide. About 80% of those subjects were given low doses of their weekly injectable weight loss medications. Researchers reported significant differences between people using weight loss medications in phase 3 clinical trials and those taking the drugs in the 'real world.' For starters, about half of those taking either medication in daily life stopped within the first 12 months. About 51% of those using a tirzepatide drug discontinued its use in that same time period. That compares with only 17% of semaglutide users and between 14% and 16% of tirzepatide users in clinical trials who quit during the first year. In addition, the average weight reduction for semaglutide participants in daily life was nearly 8% after one year while it was 12% for people taking tirzepatide. By comparison, the average weight loss in clinical trials was nearly 15% for semaglutide subjects as well as 15% for people on low dose tirzepatide and 20% for those on a higher dose of that medication. In general, weight loss was greater in people who took weight loss medications for a longer period of time. In addition, about 54% of people who had prediabetes at the start of their treatment plan improved to healthier A1C levels after one year. Around 3% of those studied progressed to type 2 diabetes after 12 months. Weight loss is a long-term commitment Mir Ali, MD, a surgeon and bariatric surgeon as well as the medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in California, said the main takeaway from this study is that weight loss is a long-term commitment. Ali wasn't involved in the new study. 'The long-term use of medications is more effective than short-term use,' Ali told Healthline. 'The study confirms that obesity is a chronic condition like diabetes or hypertension.' Sarah Kim, MD, a professor of medicine at the University of California San Francisco, noted that discontinuing medication is common for people being treated for obesity and other conditions. Kim was likewise not involved in the new study. Kim added that adherence to medication schedules as well as diet and exercise programs isn't as easy in real life because people don't have the supervision and support a person gets during a clinical trial. 'Real life is different and results aren't always as spectacular as in clinical trials,' Kim told Healthline. Kim and Ali agreed that another reason people stop taking medications is that these drugs can be expensive, even if insurance is picking up part of the cost. There is also the fact that the side effects from these medications can be severe for some people. Plus, people in real life sometimes just get tired of the obligation of taking a pill or injecting themselves on a regular basis. Ali and Kim also noted that people need to realize that medications are only a tool to help them eat less. To lose weight and keep it off, a person needs to adopt lifestyle habits such as a healthy diet and regular exercise. 'The medications are not a short-term kickstart. They don't burn fat,' said Kim. 'The medications just help with the suppression of hunger.' 'The ultimate goal of the medications is to give people a tool to get them to a healthy weight,' Ali added. What to know about GLP-1 drug for weight loss Glucagon-like peptide-1 receptor agonists (GLP-1s) work by mimicking a hormone in the body that helps regulate blood sugar levels and reduces hunger pangs. One class of the newer GLP-1 medications uses the active ingredient semaglutide. They are sold under different brand names. Ozempic and Rybelsus have been approved to treat type 2 diabetes. Wegovy is approved for use in weight management. Semaglutide drugs are available as both oral tablets and injections. The other newer group uses the active ingredient tirzepatide. Mounjaro is approved to treat type 2 diabetes. Zepbound is approved for use in weight management. These medications are available only as injections. Previous studies have highlighted the effectiveness of these drugs on helping people lose weight. Past research has also indicated that these weight loss drugs can help lower a person's risk of cancer as well as provide benefits to heart health and brain health. Experts say the medications have proven to be effective and their use is likely to increase. 'This is a massive market and it's not going to go away,' Ali said. 'These medications are going to continue to be a big part of weight loss programs.'

CNN

25 minutes ago

• CNN

Jewish GOP Congressman says he was ‘run off the road'

Jewish GOP Congressman says he was 'run off the road' GOP Rep. Max Miller said he was 'run off the road' on his way to work in Ohio by an individual who yelled "Death to Israel" and had a Palestinian flag. Miller is Jewish and describes himself as a staunch defender of Israel. 00:50 - Source: CNN Iran's foreign minister responds to Trump's call for negotiations After President Trump opened a two-week negotiating window before he decides whether to strike Iran, Iranian Foreign Minister Abbas Araghchi says the country is not seeking negotiations with the United States. 00:16 - Source: CNN Obama's energy secretary on Iran's ability to make a nuclear bomb CNN's Erin Burnett speaks with Ernest Moniz, the former US energy secretary under Obama and negotiator of the Iran nuclear deal, about the country's nuclear capabilities. 02:03 - Source: CNN CDC official who resigned warns of 'older adults dying unnecessarily' Former infectious disease expert Dr. Fiona Havers speaks with CNN's Jake Tapper after resigning from the CDC citing concerns about changes to the agency's vaccine processes under US Health and Human Services Secretary Robert F. Kennedy Jr. 01:02 - Source: CNN IAEA chief says report on Iran's nuclear program 'not new' CNN's Anderson Cooper speaks with IAEA Director General Rafael Mariano Grossi about the watchdog agency's report findings cited in part by Israeli authorities for its attacks on Iran. 03:24 - Source: CNN Scores killed in Gaza in latest Israeli strikes Israeli strikes in Gaza killed more than 70 people on Thursday, with multiple children dying. Injured children, screaming in pain, were brought to Baptist Hospital in Gaza City and other children appeared lifeless as they were carried into the ward. 00:45 - Source: CNN Video appears to show increase in aerial activity over Tehran CNN's Fred Pleitgen reports on the ground in Tehran, Iran, and witnesses increased aerial activity over the city as the Israel-Iran conflict continues. 01:02 - Source: CNN FDA approves twice-a-year shot to prevent HIV A drug already used to treat HIV has now been given FDA approval to prevent new infections, and the drugmaker says it is remarkably effective. 01:20 - Source: CNN Trump to allow two weeks before deciding on US strike in Iran In a White House briefing, Press Secretary Karoline Leavitt shared a statement from President Donald Trump regarding a US strike on Iran. 00:32 - Source: CNN Iranian missile strikes major Israeli medical center CNN's International Diplomatic Editor, Nic Robertson, reports from Beer Sheva, Israel, where a hospital was struck during an Iranian attack. Iran said it was targeting an Israeli intelligence and command center 'near a hospital.' There have been no reported deaths from the strike. 01:04 - Source: CNN Trump admin. to end 988 suicide prevention service for LGBTQ+ youth The Trump administration is ending the 988 Suicide & Crisis Lifeline's specialized services for LGBTQ+ youth on July 17. CNN's Jacqueline Howard reports. 01:01 - Source: CNN Israel's defense minister: Khamenei cannot 'continue to exist' Israel's Defense Minister Israel Katz said Iran's Supreme Leader Ayatollah Ali Khamenei cannot be allowed to 'continue to exist,' after an Israeli hospital was struck by an Iranian missile on Thursday. 00:13 - Source: CNN SpaceX Starship rocket explodes An explosion occurred late Wednesday night at SpaceX's Starbase facility in South Texas. A Starship rocket preparing for its tenth flight test experienced a 'major anomaly,' SpaceX says. There were no injuries and all employees are accounted for, according to SpaceX. The cause of the explosion and the extent of any damage are unclear. CNN has reached out to local police and fire departments for more information. 00:35 - Source: CNN Sole survivor of Air India crash mourns brother Vishwash Kumar Ramesh is the only survivor among 242 on board an Air India flight that crashed in Ahmedabad on June 12. On Wednesday Ramesh attended the funeral for his brother, who died in the tragedy. 00:30 - Source: CNN Hear former President Obama's warning about direction of the US Former President Barack Obama warned that the United States is 'dangerously close' to becoming 'consistent with autocracies' during a civic group event in Connecticut. 00:56 - Source: CNN Anne Burrell dead at 55 Anne Burrell, a chef and television personality whose joyful demeanor made her a beloved fixture on the Food Network, has died, according to the network. She was 55. 00:38 - Source: CNN NYC mayoral candidate arrested at immigration court New York City Comptroller and mayoral candidate Brad Lander was released from federal custody Tuesday afternoon, hours after he was arrested by officers at an immigration court in Manhattan when he tried to escort a migrant whom officers were attempting to arrest. 01:48 - Source: CNN Trump's new phone looks a lot like one from China The Trump Organization says its upcoming T1 smartphone will be 'proudly designed and built in the United States.' But experts tell CNN they're skeptical that goal can be achieved-- and say the T1's specifications are strikingly similar to a Chinese-made phone already on the market. 01:07 - Source: CNN This is how the US could get involved in the Israel-Iran conflict CNN's Nick Paton Walsh reports on how the US could get involved in the conflict between Israel and Iran while the countries continue trading strikes for a sixth day, with civilians in flashpoint areas facing waves of attacks. 02:14 - Source: CNN Trump's sons announce mobile phone company Trump Mobile, a wireless service created by the Trump Organization, aims to rival US carrier companies like AT&T, Verizon and T-Mobile. The Trump Organization, run by President Donald Trump's eldest sons Eric and Donald Jr., announced the business and launched a new gold smartphone for pre-order. 01:09 - Source: CNN